# EDGAR Filing Document

**Accession Number:** 0000832489
**File Stem:** 0001437749-26-012657
**Filing Date:** 2026-4
**Character Count:** 2536
**Document Hash:** ff81249ecc141ccd8fe0e2a00a4072ff
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-26-012657.hdr.sgml**: 20260519

**ACCESSION NUMBER**: 0001437749-26-012657

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260417

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GeoVax Labs, Inc.
- **CENTRAL INDEX KEY:** 0000832489
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 870455038
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 1955 LAKE PARK DRIVE
- **STREET 2:** SUITE 300
- **CITY:** SMYRNA
- **STATE:** GA
- **BUSINESS PHONE:** 678-384-7220

**MAIL ADDRESS:**
- **STREET 1:** 1955 LAKE PARK DRIVE
- **STREET 2:** SUITE 300
- **CITY:** SMYRNA
- **STATE:** GA

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Geovax Labs, Inc.
- **DATE OF NAME CHANGE:** 20061002

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DAUPHIN TECHNOLOGY INC
- **DATE OF NAME CHANGE:** 19940826

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SUCCESSO INC
- **DATE OF NAME CHANGE:** 19910410

**GeoVax Labs, Inc.**

**1955 Lake Park Drive**

**Suite 300**

**Smyrna, Georgia 30080**

**(678) 384-7220**

April 17, 2026

**<u>VIA EDGAR</u>**

Division of Corporation Finance

U.S. Securities and Exchange Commission

100 F Street N.E.

Washington, D.C. 20549

Re: GeoVax Labs, Inc. Registration Statement on Form S-1 <u>File No. 333-295082</u>

Ladies and Gentlemen:

In accordance with Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended (the "Securities Act"), GeoVax Labs, Inc., a Delaware corporation (the "Registrant"), hereby requests that the effectiveness of the registration statement on Form S-1 (File No. 333-295082) filed with the U.S. Securities and Exchange Commission on April 15, 2026, be accelerated so that the registration statement becomes effective at 5:00 p.m. Eastern Time on Tuesday, April 21, 2026 or as soon thereafter as practicable. In this regard, the Registrant is aware of its obligations under the Securities Act.

If you have any questions or comments, please contact me or if you prefer, you may contact our counsel, F. Reid Avett of Womble Bond Dickinson (US) LLP, by telephone at (202) 857-4425, or by email at reid.avett@wbd-us.com.

---

| | |
|:---|:---|
|  | Very truly yours, |
|  | GeoVax Labs, Inc. |
| By: | <u>/s/ Mark W. Reynolds</u> |
|  | Mark W. Reynolds |
|  | Chief Financial Officer |

---